These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 3108326)
1. Value of charcoal media for recovering staphylococci incorporated in mupirocin ointment. Barr JG; Hogg GM J Clin Pathol; 1987 Apr; 40(4):372-6. PubMed ID: 3108326 [TBL] [Abstract][Full Text] [Related]
2. [A trial of the use of mupirocin in the nasal carriage of Staphylococcus aureus in medical personnel]. Dmitrieva NV; Solodovnik FI; Petukhova IN Antibiot Khimioter; 2000; 45(3):35-8. PubMed ID: 10768065 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of mupirocin nasal ointment in eradicating Staphylococcus aureus nasal carriage in chronic haemodialysis patients. Holton DL; Nicolle LE; Diley D; Bernstein K J Hosp Infect; 1991 Feb; 17(2):133-7. PubMed ID: 1674259 [TBL] [Abstract][Full Text] [Related]
4. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127 [TBL] [Abstract][Full Text] [Related]
5. [Hospital personnel who are nasal carriers of methicillin-resistant Staphylococcus aureus. Usefulness of treatment with mupirocin]. Gaspar MC; Uribe P; Sánchez P; Coello R; Cruzet F Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):107-10. PubMed ID: 1643130 [TBL] [Abstract][Full Text] [Related]
6. Mupirocin-resistant Staphylococcus aureus after long-term treatment of patients with epidermolysis bullosa. Moy JA; Caldwell-Brown D; Lin AN; Pappa KA; Carter DM J Am Acad Dermatol; 1990 May; 22(5 Pt 1):893-5. PubMed ID: 2112168 [TBL] [Abstract][Full Text] [Related]
7. Dose-ranging study to assess the application of intranasal 2% mupirocin calcium ointment to eradicate Staphylococcus aureus nasal colonization. Mehta MS; Hacek DM; Kufner BA; Price C; Peterson LR Surg Infect (Larchmt); 2013 Feb; 14(1):69-72. PubMed ID: 23448592 [TBL] [Abstract][Full Text] [Related]
8. Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - a randomized double blind pilot trial. Canpolat F; Erkoçoğlu M; Tezer H; Kocabaş CN; Kandi B Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1989-93. PubMed ID: 23242727 [TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage. Doebbeling BN; Reagan DR; Pfaller MA; Houston AK; Hollis RJ; Wenzel RP Arch Intern Med; 1994 Jul; 154(13):1505-8. PubMed ID: 8018006 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of topical mupirocin against an experimental Staphylococcus aureus surgical wound infection. Boon RJ; Beale AS; Sutherland R J Antimicrob Chemother; 1985 Oct; 16(4):519-26. PubMed ID: 3934130 [TBL] [Abstract][Full Text] [Related]
11. The effect of exposure to mupirocin on the survival and recovery of sensitive Staphylococcus aureus strains. Barr JG; Hogg GM; Smyth ET Ulster Med J; 1988 Apr; 57(1):50-7. PubMed ID: 3138804 [TBL] [Abstract][Full Text] [Related]
12. Use of mupirocin ointment in the treatment of secondarily infected dermatoses. Breneman DL J Am Acad Dermatol; 1990 May; 22(5 Pt 1):886-92. PubMed ID: 2112167 [TBL] [Abstract][Full Text] [Related]
13. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Kalmeijer MD; Coertjens H; van Nieuwland-Bollen PM; Bogaers-Hofman D; de Baere GA; Stuurman A; van Belkum A; Kluytmans JA Clin Infect Dis; 2002 Aug; 35(4):353-8. PubMed ID: 12145715 [TBL] [Abstract][Full Text] [Related]
14. Unselective use of intranasal mupirocin ointment for controlling propagation of methicillin-resistant Staphylococcus aureus in a thoracic surgery ward. Mori N; Hitomi S; Nakajima J; Okuzumi K; Murakami A; Kimura S J Infect Chemother; 2005 Oct; 11(5):231-3. PubMed ID: 16258818 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus. Rouse MS; Rotger M; Piper KE; Steckelberg JM; Scholz M; Andrews J; Patel R Antimicrob Agents Chemother; 2005 Aug; 49(8):3187-91. PubMed ID: 16048923 [TBL] [Abstract][Full Text] [Related]
18. Elimination of Staphylococcus aureus carriage. Lund GC; Green DW; Ackerman NB Ann Intern Med; 1991 Jun; 114(11):990-1. PubMed ID: 1902637 [No Abstract] [Full Text] [Related]
19. The in-vitro activity of povidone-iodinecream against Staphylococcus aureus and its bioavailability in nasal secretions. Hill RL; Casewell MW J Hosp Infect; 2000 Jul; 45(3):198-205. PubMed ID: 10896798 [TBL] [Abstract][Full Text] [Related]